Health and Medical News and Resources

General interest items edited by Janice Flahiff

Hormone Therapy Statistics

From the  North American Menopause Society fact sheet Hormone Therapy Statistics

[As of July 10, 2009]

The National Prescription Audit, derived from IMS (a health care information company)Health’s Xponent, captures roughly 70% market share of all prescriptions, then uses projection methodology from a stratified and geographically balanced sample to represent 100% market share coverage of US prescription activity at retail, mail service, long-term care, and managed care outlets. Highlights include:

  • During each of the last several years, fewer prescriptions have been dispensed in the United States for menopause hormone therapy (HT). In 2008, 42.262 million prescriptions were dispensed, down 6.2% from 45.054 million during 2007. This compares to 57.861 million HT prescriptions dispensed in 2004.
  • Oral Premarin (conjugated estrogens) remained the most dispensed estrogen therapy during 2008, responsible for 23.3% of all dispensed scripts, down 13% versus 2007.
  • Oral medroxyprogesterone acetate (MPA) remained the most dispensed progestogen.
  • Estrogen-progestogen combinations were responsible for 14.8% of dispensed prescriptions during 2008, about even with 2007 levels. The most dispensed combination remained Prempro (low-dose).
  • Estrogen-androgen combinations were responsible for 4.3% of dispensed prescriptions during 2008.

October 26, 2010 Posted by | Uncategorized | , | Leave a comment


%d bloggers like this: